GOMEZ MONTERREY, ISABEL MARIA
 Distribuzione geografica
Continente #
AS - Asia 5.128
NA - Nord America 4.868
EU - Europa 3.635
SA - Sud America 687
Continente sconosciuto - Info sul continente non disponibili 287
AF - Africa 133
OC - Oceania 2
Totale 14.740
Nazione #
US - Stati Uniti d'America 4.642
SG - Singapore 2.333
RU - Federazione Russa 1.527
CN - Cina 971
VN - Vietnam 884
IT - Italia 663
BR - Brasile 569
HK - Hong Kong 402
UA - Ucraina 243
DE - Germania 215
FR - Francia 192
FI - Finlandia 163
NL - Olanda 149
IE - Irlanda 132
CA - Canada 119
SE - Svezia 104
BD - Bangladesh 103
GB - Regno Unito 98
IN - India 93
JP - Giappone 71
MX - Messico 49
AR - Argentina 43
ZA - Sudafrica 40
ES - Italia 33
AT - Austria 32
CI - Costa d'Avorio 32
KR - Corea 30
TR - Turchia 29
PH - Filippine 26
TH - Thailandia 26
ID - Indonesia 25
PL - Polonia 24
CO - Colombia 21
IQ - Iraq 19
EC - Ecuador 17
TW - Taiwan 13
UZ - Uzbekistan 12
JM - Giamaica 11
PK - Pakistan 11
AE - Emirati Arabi Uniti 9
CL - Cile 9
CR - Costa Rica 9
MA - Marocco 9
BE - Belgio 8
KE - Kenya 8
VE - Venezuela 8
BG - Bulgaria 7
EG - Egitto 7
IL - Israele 7
MY - Malesia 7
PE - Perù 7
SA - Arabia Saudita 7
CZ - Repubblica Ceca 6
GT - Guatemala 6
PT - Portogallo 6
PY - Paraguay 6
TT - Trinidad e Tobago 6
DZ - Algeria 5
GE - Georgia 5
GR - Grecia 5
HN - Honduras 5
IR - Iran 5
LT - Lituania 5
NP - Nepal 5
UY - Uruguay 5
AZ - Azerbaigian 4
BB - Barbados 4
DO - Repubblica Dominicana 4
ET - Etiopia 4
JO - Giordania 4
NG - Nigeria 4
TN - Tunisia 4
AM - Armenia 3
BS - Bahamas 3
KG - Kirghizistan 3
KZ - Kazakistan 3
SY - Repubblica araba siriana 3
UG - Uganda 3
AL - Albania 2
AO - Angola 2
AU - Australia 2
BA - Bosnia-Erzegovina 2
BY - Bielorussia 2
BZ - Belize 2
CW - ???statistics.table.value.countryCode.CW??? 2
CY - Cipro 2
DK - Danimarca 2
EE - Estonia 2
GA - Gabon 2
GH - Ghana 2
HR - Croazia 2
HU - Ungheria 2
LB - Libano 2
LK - Sri Lanka 2
MD - Moldavia 2
NI - Nicaragua 2
OM - Oman 2
PA - Panama 2
RO - Romania 2
SN - Senegal 2
Totale 14.428
Città #
Singapore 1.020
San Jose 766
Chandler 439
Moscow 404
Hong Kong 391
Beijing 313
Ashburn 305
Ho Chi Minh City 250
Jacksonville 237
Hanoi 181
Santa Clara 154
The Dalles 140
Princeton 134
Lauterbourg 127
Council Bluffs 121
Los Angeles 118
Amsterdam 112
Millbury 112
Nanjing 107
Napoli 107
Naples 104
Hefei 81
Buffalo 79
Dallas 74
New York 66
São Paulo 64
Boston 60
Des Moines 59
Ottawa 54
Tokyo 54
Wilmington 48
Redondo Beach 43
Munich 41
Haiphong 40
Orem 40
Phoenix 40
Da Nang 35
Seattle 30
Chicago 29
Dong Ket 28
Brooklyn 26
Biên Hòa 24
Fisciano 24
Salerno 24
London 23
Montreal 23
Turku 23
Mexico City 22
Warsaw 22
Atlanta 21
Frankfurt am Main 21
Nanchang 21
Shenyang 21
Rome 20
Hebei 19
Johannesburg 19
Kronberg 19
Rio de Janeiro 19
Stockholm 19
Tianjin 19
Chennai 18
Houston 17
Jiaxing 17
Seoul 17
Woodbridge 17
Changsha 16
Denver 16
Bangkok 15
Hải Dương 15
San Francisco 15
Falkenstein 14
Lawrence 14
Milan 14
Brasília 13
Charlotte 12
Poplar 12
Can Tho 11
Curitiba 11
Norwalk 11
Nuremberg 11
Parma 11
Tashkent 11
Vienna 11
Bắc Giang 10
Helsinki 10
Toronto 10
Boardman 9
Goiânia 9
Manchester 9
Miami 9
Thái Nguyên 9
Ankara 8
Campinas 8
Dublin 8
Guangzhou 8
Kochi 8
Manaus 8
Nakano 8
North Bergen 8
Paris 8
Totale 7.502
Nome #
Short-length derivatives of cell-penetrating peptides for ocular drug delivery 235
Beyond Retigabine: Design, Synthesis, and Pharmacological Characterization of a Potent and Chemically Stable Neuronal Kv7 Channel Activator with Anticonvulsant Activity 214
Characterization of New TRPM8 Modulators in Pain Perception 174
New Antiviral INSTIs: Design, Synthesis And Biological Evaluation. 167
Tryptamine-based derivatives as Transient Receptor Potential Melastatin type-8 (TRPM8) channel modulators 161
An investigation into the origin of the biased agonism associated with the urotensin II receptor activation 160
Pursuing the Development of New Antiviral INSTIs 158
1,3-Dioxoperhydropyrido[2,1-c]pyrimidine derivatives as Cholecyctokinin antagonista 157
Integrating GRK2 and NFkappaB in the Pathophysiology of Cardiac Hypertrophy 157
Discovery and Optimization of Indoline-Based Compounds as Dual 5-LOX/sEH Inhibitors: In Vitro and In Vivo Anti-Inflammatory Characterization 155
Lead Optimization of P5U and Urantide: Discovery of Novel Potent Ligands at the Urotensin-II Receptor 145
Synthesis of a New Series of [Indoline3, 2’-thiazolidine] - Based p53 modulators 143
N-substitued tryptamines as TRPM8 channel modulators 141
Design, Synthesis, and Pharmacological Characterization of a Potent Soluble Epoxide Hydrolase Inhibitor for the Treatment of Acute Pancreatitis 141
Design, Synthesis, and Cytotoxic Evaluation of AcylDerivatives of 3-Aminonaphtho[2,3-b]thiophene-4,9-dione, a Quinone-Based System 140
Investigation on side-product formation during the synthesis of a lactoferrin-derived lactam-bridged cyclic peptide 140
Novel approach to the synthesis of diaza-bridged heterocycle derivative. 139
Continuous-flow synthesis of thiazolidine libraries: one-pot two steps protocol optimization 139
D-Amino Acids Containing Temporin L Analogues 138
Structure-Activity Study of the Peptides P5U and Urantide by the Development of Analogues Containing Uncoded Amino Acids at Position9 138
Synthesis and Pharmacological Characterization of Conformationally Restricted Retigabine Analogues as Novel Neuronal Kv7 Channel Activators 137
Pursuing the Development of New Antiviral Entry Inhibitors 135
Novel α-MSH peptide analogues with broad spectrum antimicrobial activity. 134
DTNQ-based anticancer derivatives as selective glucose penetration inhibitors 134
Exploration of TRPM8 Binding Sites by β-Carboline-Based Antagonists and Their In Vitro Characterization and In Vivo Analgesic Activities 134
Synthesis of novel indol-based ring systems by acid-catalyzed condensation from -amino aldehydes and L-Trp-OMe 131
New insight into the binding mode of peptides at urotensin-II receptor by Trp-constrained analogues of P5U and urantide. 130
Design, synthesis and efficacy of novel G protein-coupled receptor kinase 2 inhibitors 129
Synthesis of new pyrido[4,3-g and 3,4-g]quinoline-5,10-dione and dihydro thieno[[2,3-g and 3,2-g]quinoline-4,9-dione derivatives and perliminary evaluation of cytotoxic activity 125
SAR study and conformational analysis of a series of novel peptide G protein-coupled receptor kinase 2 inhibitors 125
Targeting the CaMKII/ERK Interaction in the Heart Prevents Cardiac Hypertrophy 125
Antioxidant profile and in vitro antiproliferative and cardioprotective properties of typical red and white wines from vineyards cultivated in Scafati (Salerno, Italy) 123
Improvement of the activity of the anti-HIV-1 integrase aptamer T30175 by introducing a modified thymidine into the loops 123
Design and synthesis of the small libraries of peptidomimetics based on thiazolidine moiety 122
N-substituted tryptamines as TRPM8 channel modulators 122
Dihydrithieno[2,3-b]naphto-4,9-dione analogues as anticancer agents: Synthesis and in cell pharmacological studies. 121
A novel quinone–based derivative (DTNQ-Pro) induces apoptotic death via modulation/reduction of hsp expression in a human colon adenocarcinoma cell line 120
Urantide Conformation and Interaction with the Urotensin-II Receptor 120
Design and Synthesis of Spirotryprostatin-inspired Diketopiperazine Systemsfrom Prolyl Spirooxoindolethiazolidine Derivatives 118
New small molecules, ISA27 and SM13, inhibit tumour growth inducing mitochondrial effects of p53 117
Development of Cyclic Peptide Inhibitors of GRK2 116
Morphicetin analogues containing a new β-turn thiazolidine mimetic 115
Identification of the Spiro(oxindole-3,3’-thiazolidine)-Based Derivatives as Potential p53 Activity Modulators 115
A De Novo Designed Library of Linear Helical Peptides: An Exploratory Tool in the Discovery of Protein-Protein Interaction Modulators 115
Sar Study Of P5u And Urantide Analogues Modified At Position 9 115
A novel route to synthesize Freidinger lactams by microwave irradiation 114
SAR Study and Conformational Analysis of a Series of Novel GRK2 Peptide inhibitors 108
Combinatorial Approach in the Synthesis of a Small Library of β-Turn Structures Based on Thiazolidine Moiety 106
New TRPM8 blockers exert anticancer activity over castration-resistant prostate cancer models 103
An efficient synthesis of 8-Amino-3-oxoindolizidine-2-carboxylic acid and derivarives as model peptidomimetics 102
Synthesis, in vitro, and in cell studies of a new series of [Indoline-3,2'-thiazolidine]-based p53 modulators. 102
Spiro[(dihydropyrazin-2,5-dione)-6,3’-(2’,3’-dihydrothieno[2,3-b]naphtho-4’,9’-dione)]-Based Cytotoxic Agents: Structure-Activity Relationship Studies on the Substituent at N4-Position of the Diketopiperazine Domain 101
SAR Study on CN17β a Potent and Selective CaMKII Peptide Inhibitor 101
An Efficient Approach to Aromatic Aminomethylation Using Dichloromethane as Methylene Source 99
5-(Tryptophyl)amino-1,3-dioxoperhidropyrido[1,2-c]pyrimidine-based potent and selective CCK1 receptor antagonists: Structure-activity relationship studies on the substituents at N2-position 98
An efficient approach for monosulfide bridge formation in solid-phase peptide synthesis 98
Identification of an indol-based multi-target kinase inhibitor through phenotype screening and target fishing using inverse virtual screening approach 97
DESIGN, SYNTHESIS AND CONFORMATIONAL STUDIES OF NEW ANALOGUES OF TEMPORINS A AND L 96
Synthesis of 2-Alkyl(aryl)amino-(3,4,6-tri-O-acetyl-1,2-dideoxy-a-D-glucopirano)[2,1-d]-2-oxazolines and ethyl 2-[3-alkyl(aryl)ureido]-2-deoxy-b-D-glucopiranosides from acetylated 2-[3-alkyl(aryl)ureido]-2-deoxy-D-glucopyranoses 95
Le concept d’inhibiteaurs mixtes des metallopeptidase a Zinc: application au developement de noveaux analgesiques et antihypertensives 95
Tioureas derivadas de carbohidratos V. Isotiocianato y tioureas dela 2-Amino-2-desoxi-D-glicero-α-L-glucoheptopiranosa 95
D-Amino Acids Containing Temporin L Analogues 93
Development and Identification of a Novel Anti-HIV-1 Peptide Derived by Modification of the N-Terminal Domain of HIV-1 Integrase 92
A facile synthesis of 8-Amino-3-oxoindolizidine derivatives as conformationally restricted ornithyl pseudodipeptides. 91
P5U and urantide modifi ed at position 7 with Tpi 91
Phenacylthiourea and N-thiazolyl derivatives of D-glucasamine 89
Synthesis of cyclic ketomethylene dipeptides 89
Identification of novel microsomal prostaglandin E2 synthase-1 (mPGES-1) lead inhibitors from fragment Virtual Screening 89
Synthesis of quinolindione derivatives assisted by microwave irradiation 88
Synthesis of Ketomethylene-bestatine 86
Cell penetrating peptides in ocular drug delivery: State of the art 86
New insight into the binding mode of peptide ligands at Urotensin-II receptor: structure-activity relationships study on P5U and urantide 85
A new series of 1,3-dihydro-imidazo[1,5-c]thiazole-5,7-dione derivatives: synthesis and interaction with Aβ (25-35) amyloid peptide 84
Synthesis and antimicrobial evaluation of Temporin L analogues containing D-amino acids 84
Novel peptidomimetic as MMP2 inhibitors 84
Identification of a Potent Tryptophan-based TRPM8 Antagonist With in vivo Analgesic Activity 84
5-(Tryptophyl)amino-1,3-dioxoperhidropyrido[1,2-c]pyrimidine-based potent and selective CCK1 receptor antagonists: Structural modifications at the Tryptophan domain 83
Ketomethylenebestatine. Synthesis and aminopeptidase inhibition 83
Design Synthesis and biological evaluation of new HIV-1 entry inhibitors 83
Antioxidant and oxidative effects of grape juices 83
Morphiceptin Analogues Containing a Dipeptide Mimetic Structure: An Investigation on the Bioactive Topology at μ-Receptor 82
Amino acid derivatives as new zinc binding groups for the design of selective matrix metalloproteinase inhibitors 82
Sintesis de hidrobromuros de Glucopirano-[2,1-d]-2-tiazolidinas 81
Conformational stability of a(25-35) in the presence of thiazolidine and imidazo[1,5-c]thiazole-5,7-dione derivatives 81
Antioxidant profile and in vitro cardiac radical-scavenging vs pro-oxidant effects of commercial red grape juices (Vitis vinifera L. cv. Aglianico N.). 81
Synthesis and biological activities of ketomethylene-substituted analogs of neurotensin(8-13) 80
Characterization of a selective CaMKII peptide inhibitor 80
New Frontiers on ER Stress Modulation: Are TRP Channels the Leading Actors? 79
Synthesis of Glicofurano[2,1-d]imidazolidin-2-ones 78
Prolonged antinociceptive activity of pseudodipeptide analogues of Lys- Trp(Nps) and Trp(Nps)-Lys 78
Design, synthesis and Cytotoxic Evaluation of a New Series of 3-Substituted-spiro[(dihydropirazin-2,5-dione)-6,3’-(2’,3’-dihydrothieno[2,3-b]naphtho-4’,9’-dione)] Derivatives 78
Biological activity of 3-chloro-azetidin-2-one derivatives having interesting antiproliferative activity on human breast cancer cell lines. 78
In Silico Identification and In Vitro Evaluation of New ABCG2 Transporter Inhibitors as Potential Anticancer Agents 76
Transient Receptor Potential Melastatin 8 Channel (TRPM8) Modulation: Cool Entryway for Treating Pain and Cancer 76
Pharmacological evaluation of IQM-95,333, a highly selective CCK-A receptor antagonist with anxyolitic-like activity in animal models. 75
Stereospecific synthesis of (2R,3S)-3-Amino-2-piperidineacetic acid derivatives for use as conformational constraint in peptides 75
Synthesis of 1,3,4,6-Tetra-O-acetyl-2-[3-alkyl(aryl)thioureido]-2-deoxy-a-D-glucopiranoses and their transformation into 2-Alkyl(aryl)amino-(1,2-dideoxy-a-D-glucopirano)[2,1-d]-2-thiazolidines 75
Conformational analysis of the new temporin analogues: Gln3TA and Pro3TL 74
Design, Synthesis and Conformational Studies of New Analogues of Temporins A and L. 74
An Effective Virtual Screening Protocol to Identify Promising p53-MDM2 Inhibitors 73
Totale 11.056
Categoria #
all - tutte 51.547
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.547


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022656 0 0 2 14 6 30 11 16 133 48 125 271
2022/2023984 160 65 25 113 111 105 8 88 140 109 40 20
2023/2024547 21 80 68 24 32 32 9 66 13 15 134 53
2024/20253.459 189 188 46 25 58 159 397 201 371 357 1.194 274
2025/20266.715 717 502 692 674 1.105 253 684 402 820 478 226 162
2026/2027533 164 198 171 0 0 0 0 0 0 0 0 0
Totale 14.740